3KK: S-{(3R,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} 2-hydroxy-2-methylpropanethioate
3KK is a Ligand Of Interest in 7PT2 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 7PT2_3KK_B_702 | 98% | 50% | 0.046 | 0.98 | 1.05 | 0.78 | 5 | - | 1 | 0 | 100% | 1 |
| 7PT2_3KK_A_702 | 95% | 49% | 0.059 | 0.972 | 0.93 | 0.92 | 2 | 5 | 0 | 0 | 100% | 1 |
| 7PT3_3KK_B_702 | 100% | 54% | 0.017 | 0.997 | 0.75 | 0.88 | 1 | 5 | 0 | 0 | 100% | 1 |
| 9QZ4_3KK_B_702 | 100% | 55% | 0.019 | 0.996 | 0.59 | 0.97 | - | 4 | 2 | 0 | 100% | 1 |
| 7PT1_3KK_B_702 | 97% | 52% | 0.05 | 0.977 | 0.97 | 0.77 | 4 | 1 | 2 | 0 | 100% | 1 |
| 9QZ5_3KK_B_701 | 95% | 49% | 0.06 | 0.97 | 0.73 | 1.13 | 2 | 4 | 2 | 0 | 100% | 1 |
| 4R3U_3KK_A_802 | 91% | 20% | 0.07 | 0.962 | 1.64 | 1.67 | 8 | 12 | 3 | 0 | 100% | 0.5 |
